Βeta-Cells: Stress, Identity, Failure and Diabetes

TL;DR

This paper reviews how pancreatic β-cell dysfunction contributes to diabetes and explores potential strategies to prevent or treat it.

Contribution

The paper provides a comprehensive review of β-cell failure mechanisms and their implications for diabetes treatment.

Findings

Dysfunctional β-cells are linked to reduced insulin production and glucose homeostasis disruption.

β-cell heterogeneity influences stress responses and diabetes risk.

ER stress, mitochondrial dysfunction, and inflammation are key drivers of β-cell failure.

Abstract

What are the main findings?
Dysfunctional β-cell populations are linked to reduced insulin production and secretion, thereby affecting glucose homeostasis.β-cell heterogeneity leads to variable stress-response patterns, thereby influencing the risk of progressive diabetes.

Dysfunctional β-cell populations are linked to reduced insulin production and secretion, thereby affecting glucose homeostasis.

β-cell heterogeneity leads to variable stress-response patterns, thereby influencing the risk of progressive diabetes.

What are the implications of the main finding?
Avoiding glucotoxicity, lipotoxicity and ER stress will aid diabetes prevention and treatment.Developing alternative therapies, such as β-cell replacement or anti-diabetic agents that re-active insulin secretion, can open new avenues for diabetes treatment.

Avoiding glucotoxicity, lipotoxicity and ER stress will aid diabetes prevention and treatment.

Developing alternative therapies, such as β-cell replacement or anti-diabetic agents that re-active insulin secretion, can open new avenues for diabetes treatment.

Type 2 diabetes (T2D) is a pressing global health challenge, primarily driven by modern dietary and lifestyle patterns. Central to T2D progression is the dysfunction of insulin-secreting pancreatic β-cells, which critically disrupts glucose homeostasis. The progression to T2D relies on the β-cells’ inability to compensate for increasing insulin resistance. Initially, β-cells enhance the insulin output, but chronic nutrient overload, ER stress and inflammation ultimately compromise their function and survival. This review examines the molecular and cellular drivers of β-cell failure, focusing on endoplasmic reticulum stress, mitochondrial dysfunction and inflammatory pathways amid chronic metabolic stress. We also explore the loss of β-cell identity and altered interactions within the islet microenvironment. Understanding these mechanisms is essential for developing strategies to prevent β-cell dysfunction and slow T2D progression, ultimately supporting better metabolic health outcomes.

Figures